EUVIMEDEUVIMED entdecken
Crossref

Engagement of an optimized lentiviral vector enhances the expression and cytotoxicity of CAR in human NK cells

Changjiang Guo, Han Chen, Jie Yu, Hui Lu, Qing Xia, Xiaojuan Li, Xiali Guo, Tong Wang, Lingtong Zhi, Zhiyuan Niu, Wuling Zhu

Molecular Immunology · 2023-03 · 155 · 91-99

DOI: 10.1016/j.molimm.2023.01.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Immunology, 2023-03. Verfasst von Changjiang Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Synthetic Biology Engineering Lab of Henan Province, School of Life Sciences and Technology, Xinxiang Medical University, Xinxiang, Henan Province, P…. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adoptive chimeric antigen receptor (CAR)-modified T or NK cells (CAR-T/NK) have emerged as a novel form of disease treatment. Lentiviral vectors (LVs) are commonly employed to engineer NK cells for the efficient expression of CARs. This study reported the influence of single-promoter and dual-promoter LVs on the CAR expression and cytotoxicity of engineered NK cells. We constructed a third-generation NKG2D-based CAR that kills cancer cells by targeting up to eight stress-induced ligands (NKG2DLs). Our results demonstrated that the CAR exhibits both a higher expression level and a higher coexpression concordance with the GFP reporter in HEK-293T or NK92 cells by utilizing the optimized single-promoter pCDHsp rather than the original dual-promoter pCDHdp. After puromycin selection, the pCDHsp produces robust CAR expression and enhanced in vitro cytotoxicity of engineered NK cells. Therefore, infection with a single-promoter pCDHsp lentivector is recommended to prepare CAR-engineered NK cells. This research helps to optimize the production of CAR-NK cells and enhance their functional activity, to provide CAR-NK cell products with better and more uniform quality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenHumansGenetic VectorsKiller Cells, NaturalImmunotherapy, AdoptiveCell Line, TumorCytotoxicity, Immunologic

Stichwörter der Autor:innen

Chimeric antigen receptorLentiviral vectorPromoterSelf-cleaving P2A peptideVector optimization

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Synthetic Biology Engineering Lab of Henan Province, School of Life Sciences and Technology, Xinxiang Medical University, Xinxiang, Henan Province, PR China. Electronic address: changjiangguo@xxmu.edu.cn.
  • Synthetic Biology Engineering Lab of Henan Province, School of Life Sciences and Technology, Xinxiang Medical University, Xinxiang, Henan Province, PR China.
  • Synthetic Biology Engineering Lab of Henan Province, School of Life Sciences and Technology, Xinxiang Medical University, Xinxiang, Henan Province, PR China. Electronic address: wuling_zhu@163.com.

Zitieren

APA

Guo, C., Chen, H., Yu, J., Lu, H., Xia, Q., Li, X., Guo, X., Wang, T., Zhi, L., Niu, Z., & Zhu, W. (2023). Engagement of an optimized lentiviral vector enhances the expression and cytotoxicity of CAR in human NK cells. Molecular Immunology, 155, 91-99. https://doi.org/10.1016/j.molimm.2023.01.010

Vancouver

Guo C, Chen H, Yu J, Lu H, Xia Q, Li X, et al. Engagement of an optimized lentiviral vector enhances the expression and cytotoxicity of CAR in human NK cells. Molecular Immunology. 2023;155:91-99. doi:10.1016/j.molimm.2023.01.010

BibTeX
@article{Guo2023,
  author = {Guo, Changjiang and Chen, Han and Yu, Jie and Lu, Hui and Xia, Qing and Li, Xiaojuan and Guo, Xiali and Wang, Tong and Zhi, Lingtong and Niu, Zhiyuan and Zhu, Wuling},
  title = {Engagement of an optimized lentiviral vector enhances the expression and cytotoxicity of CAR in human NK cells},
  journal = {Molecular Immunology},
  year = {2023},
  volume = {155},
  pages = {91--99},
  doi = {10.1016/j.molimm.2023.01.010}
}
Kostenlos starten →